Susquehanna International Group’s Immix Biopharma IMMX Stock Holding History

Susquehanna International Group’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.29M	Buy	471,394 +77,507	+20%	+$569K	﹤0.01%	4521
2025 Q4	$2.06M	Buy	393,887 +303,029	+334%	+$1.25M	﹤0.01%	5599
2025 Q3	$190K	Buy	90,858 +40,032	+79%	+$96.1K	﹤0.01%	11049
2025 Q2	$105K	Sell	50,826 -4,436	-8%	-$8.93K	﹤0.01%	11771
2025 Q1	$92.8K	Buy	+55,262	New	+$104K	﹤0.01%	11584
2024 Q2	–	Sell	-76,901	Closed	-$236K	–	12602
2024 Q1	$236K	Buy	76,901 +62,550	+436%	+$242K	﹤0.01%	10241
2023 Q4	$99.3K	Buy	+14,351	New	+$65K	﹤0.01%	11339
2023 Q2	–	Sell	-17,723	Closed	-$32.3K	–	12573
2023 Q1	$32.3K	Buy	+17,723	New	+$39.2K	﹤0.01%	11883

Other funds holding IMMX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Susquehanna International Group's IMMX Position: Q1 2026 in Review

Susquehanna International Group increased its Immix Biopharma (IMMX) stake by 20% in Q1 2026, buying an estimated $569K and bringing the position to 471,394 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4521.

Susquehanna International Group first reported a position in IMMX in Q1 2023 and has held it in 8 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

Susquehanna International Group held 471,394 shares of Immix Biopharma worth $4.29M as of Q1 2026.
Susquehanna International Group bought 77,507 Immix Biopharma shares in Q1 2026, an estimated $569K.
Immix Biopharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4521 holding.
Susquehanna International Group first reported a position in Immix Biopharma in Q1 2023 and has held it in 8 quarters since.
77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.